|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
14,240,000 |
Market
Cap: |
180.71(M) |
Last
Volume: |
231,508 |
Avg
Vol: |
229,644 |
52
Week Range: |
$5.51 - $25.62 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 5.9 |
Insider 6 Months : 5.9 |
Insider 3/6 Months : 12.1 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Lifevantage engages in the identification, research, development, formulation and sale of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and other products. Co.'s line of dietary supplements includes its primary Protandim® family of products, LifeVantage® Omega+, ProBio, IC Bright®, and Daily Wellness dietary supplements. TrueScience® is Co.'s line of skin, hair, bath and body, and other products. Co. also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio®, its nootropic energy drink mixes, and PhysIQ, its weight management system.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
2,529 |
2,529 |
4,707 |
66,756 |
Total Buy Value |
$31,210 |
$31,210 |
$50,308 |
$368,140 |
Total People Bought |
2 |
2 |
2 |
4 |
Total Buy Transactions |
3 |
3 |
7 |
22 |
Total Shares Sold |
0 |
18,300 |
18,300 |
23,800 |
Total Sell Value |
$0 |
$364,620 |
$364,620 |
$397,620 |
Total People Sold |
0 |
3 |
3 |
3 |
Total Sell Transactions |
0 |
3 |
3 |
4 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lewis Darwin |
Director |
|
2025-06-13 |
4 |
AB |
$12.78 |
$4,873 |
D/D |
379 |
116,767 |
|
2% |
|
Mauro Garry Paul |
Director |
|
2025-05-09 |
4 |
B |
$12.25 |
$18,975 |
I/I |
1,549 |
6,598 |
2.1 |
3% |
|
Mauro Garry Paul |
Director |
|
2025-05-09 |
4 |
B |
$12.25 |
$7,362 |
D/D |
601 |
86,087 |
2.39 |
3% |
|
Cunningham Kristen |
Chief Sales Officer |
|
2025-04-28 |
4 |
D |
$12.14 |
$44,420 |
D/D |
(3,659) |
104,388 |
|
- |
|
Cunningham Kristen |
Chief Sales Officer |
|
2025-04-01 |
4 |
D |
$15.79 |
$53,544 |
D/D |
(3,391) |
107,549 |
|
- |
|
Cunningham Kristen |
Chief Sales Officer |
|
2025-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
110,940 |
|
- |
|
Aure Carl |
Chief Financial Officer |
|
2025-04-01 |
4 |
D |
$15.79 |
$43,407 |
D/D |
(2,749) |
132,058 |
|
- |
|
Aure Carl |
Chief Financial Officer |
|
2025-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,401 |
134,807 |
|
- |
|
Neufeld Alissa |
General Counsel |
|
2025-04-01 |
4 |
D |
$15.79 |
$44,196 |
D/D |
(2,799) |
91,701 |
|
- |
|
Neufeld Alissa |
General Counsel |
|
2025-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,667 |
94,500 |
|
- |
|
Boyster Julie |
Chief Marketing Officer |
|
2025-04-01 |
4 |
D |
$15.79 |
$62,781 |
D/D |
(3,976) |
115,517 |
|
- |
|
Boyster Julie |
Chief Marketing Officer |
|
2025-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,668 |
119,493 |
|
- |
|
Fife Steven R |
President and CEO |
|
2025-04-01 |
4 |
D |
$15.79 |
$332,995 |
D/D |
(21,089) |
632,371 |
|
- |
|
Boyster Julie |
Chief Marketing Officer |
|
2025-02-17 |
4 |
D |
$18.56 |
$53,638 |
D/D |
(2,890) |
115,825 |
|
- |
|
Beindorff Michael A |
Director |
|
2025-02-10 |
4 |
S |
$19.54 |
$114,309 |
D/D |
(5,850) |
44,168 |
|
40% |
|
Latham Cynthia |
Director |
|
2025-02-10 |
4 |
S |
$20.02 |
$89,089 |
D/D |
(4,450) |
51,348 |
|
40% |
|
Greer Raymond B |
Director |
|
2025-02-10 |
4 |
S |
$20.15 |
$161,222 |
D/D |
(8,000) |
99,288 |
|
40% |
|
Boyster Julie |
Chief Marketing Officer |
|
2025-01-01 |
4 |
D |
$17.53 |
$54,290 |
D/D |
(3,097) |
118,715 |
|
- |
|
Boyster Julie |
Chief Marketing Officer |
|
2025-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,667 |
121,812 |
|
- |
|
Neufeld Alissa |
General Counsel |
|
2025-01-01 |
4 |
D |
$17.53 |
$55,342 |
D/D |
(3,157) |
91,833 |
|
- |
|
Neufeld Alissa |
General Counsel |
|
2025-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,668 |
94,990 |
|
- |
|
Aure Carl |
Chief Financial Officer |
|
2025-01-01 |
4 |
D |
$17.53 |
$57,306 |
D/D |
(3,269) |
132,406 |
|
- |
|
Aure Carl |
Chief Financial Officer |
|
2025-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,401 |
135,675 |
|
- |
|
Cunningham Kristen |
Chief Sales Officer |
|
2025-01-01 |
4 |
D |
$17.53 |
$46,314 |
D/D |
(2,642) |
107,940 |
|
- |
|
Cunningham Kristen |
Chief Sales Officer |
|
2025-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,001 |
110,582 |
|
- |
|
435 Records found
|
|
Page 1 of 18 |
|
|